Technical University of Munich, Chair of Biological Imaging at the Central Institute for Translational Cancer Research (TranslaTUM), School of Medicine, Munich, Germany.
Institute of Biological and Medical Imaging, Helmholtz Zentrum München, Neuherberg, Germany.
J Biomed Opt. 2023 Apr;28(4):046001. doi: 10.1117/1.JBO.28.4.046001. Epub 2023 Apr 5.
Intravascular near-infrared fluorescence (NIRF) imaging aims to improve the inspection of vascular pathology using fluorescent agents with specificity to vascular disease biomarkers. The method has been developed to operate in tandem with an anatomical modality, such as intravascular ultrasound (IVUS), and complements anatomical readings with pathophysiological contrast, enhancing the information obtained from the hybrid examination.
However, attenuation of NIRF signals by blood challenges NIRF quantification. We propose a new method for attenuation correction in NIRF intravascular imaging based on a fluorophore-coated guidewire that is used as a reference for the fluorescence measurement and provides a real-time measurement of blood attenuation during the NIRF examination.
We examine the performance of the method in a porcine coronary artery and phantoms using a 3.2F NIRF-IVUS catheter.
We demonstrate marked improvement over uncorrected signals of up to 4.5-fold and errors of for target signals acquired at distances up to 1 mm from the catheter system employed.
The method offers a potential means of improving the accuracy of intravascular NIRF imaging under conditions.
血管内近红外荧光(NIRF)成像是一种利用对血管疾病生物标志物具有特异性的荧光剂来改善血管病理学检查的方法。该方法旨在与解剖模态(如血管内超声(IVUS))联合使用,并通过病理生理学对比来补充解剖学读数,从而增强从混合检查中获得的信息。
然而,血液对 NIRF 信号的衰减挑战了 NIRF 定量。我们提出了一种基于荧光标记导丝的 NIRF 血管内成像衰减校正新方法,该导丝用作荧光测量的参考,并在 NIRF 检查期间实时测量血液衰减。
我们使用 3.2F NIRF-IVUS 导管在猪冠状动脉和体模中检查该方法的性能。
我们证明,与未校正的信号相比,标记导丝可将信号提高高达 4.5 倍,并且在距离导管系统 1mm 以内采集的目标信号的误差为 。
该方法为改善条件下的血管内 NIRF 成像的准确性提供了一种潜在的手段。